Mus vs United Arab Emirates: Treatment success rate for patients treated for MDR-TB
Mus
100.0%
in 2022
United Arab Emirates
100.0%
in 2022
Mus rank
1st
United Arab Emirates rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Mus
- United Arab Emirates
How they compare
Mus currently reports 100.0% against 100.0% in United Arab Emirates, a difference of 0.0%.
The two have swapped places 4 times across 8 shared years of data; in 2007 it was United Arab Emirates ahead.
Mus ranks 1st and United Arab Emirates ranks 1st of 1 regions.
Mus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mus | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 73.4% | 20.0% | 53.4% | Mus |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Mus or United Arab Emirates?
- Mus, at 100.0% against 100.0% in United Arab Emirates as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Mus and United Arab Emirates?
- 0.0%, with Mus ahead.
- How many years of comparable data are there for Mus and United Arab Emirates?
- 8 years are reported by both, from 2007 to 2022.
- How do Mus and United Arab Emirates rank globally for treatment success rate for patients treated for mdr-tb?
- Mus ranks 1st and United Arab Emirates ranks 1st of 1 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.